Navigation Links
PaedRegCliNet e.V.: A Boost for Safe Pediatric Medications
Date:11/19/2010

ations for children.

Paving the way for clinical studies with children

But implementing this extremely positive endeavor has run into two major obstacles. "Because there have hardly been any clinical studies with children, many doctors at pediatric clinics do not have the necessary training," says Prof Dieter Adam. And that is why he founded the association PaedRegCliNet e.V. together with other pediatric specialists. It offers doctors at pediatric clinics one to two-day courses, which provide them with the basis for clinical studies in pediatrics, from the necessary infrastructure to the monitoring and implementation at testing centers. These courses were presented in detail at a symposium held at the Dr. Haunerschen Kinderspital of the University of Munich on September 29, 2010.

Ethical obligation overrides profit

The second problem encountered in implementing the Pediatric Regulation is finding a pharmaceutical company to finance the study. An EU proposal does contain a mention of assuming up to 50 percent of the costs of research on particular medications. "But for companies this does not appear to be attractive," explains Prof Adam.

"Compared to adults, children are not a revenue driver." He explained this fact by using the example of high blood pressure. A medication for high blood pressure approved for adults will be prescribed to millions of patients. If the medication is to be tested to see if it is safe for babies who suffer from high blood pressure due to a congenital heart disease, there are only a few thousand young patients worldwide who would be prescribed this medication. This is why PaedRegCliNet e.V. is also committed to finding pharmaceutical companies, raising awareness of the EU regulation and to underscoring the ethical obligation.

Lowering the costs of the studies

In an effort to keep the costs of the studies as low as possible and to consequently burden pharmaceutical companies as little
'/>"/>

SOURCE PaedRegCliNet. e.V.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Prolong Pharmaceuticals Boosts Executive Team
2. ALS Research Gets a $4.1 Million Boost from CVS/pharmacy Fundraising Campaign
3. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
4. George Soros to Boost Civil Society Response in Flood Affected Areas of Pakistan
5. Study Seeks Volunteers to Measure Safety of Treatment Boost for Patients with Oropharyngeal Cancer
6. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
7. MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimers Disease Trials
8. Verizon Business Adds Riverbed Application Acceleration Technology, New Consulting Services to Boost Performance of Key Business Applications
9. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
10. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
11. Widening Application Range to Boost MRI Markets in Eastern Europe, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... The SCOOTER Store today announced a major milestone, saying it has ... power wheelchair to Earvin Thompson of Houston, Texas . ... leading provider of power mobility equipment, will enjoy more freedom and independence ... , ...
... GRONINGEN, The Netherlands , June 22, 2010 ... announced this week that in collaboration,with the University ... for the treatment of inhalation anthrax. In a rabbit ... time to treatment (48h post,infection) with a combination of ...
Cached Medicine Technology:The SCOOTER Store Marks Half-Millionth Life Changed 2The SCOOTER Store Marks Half-Millionth Life Changed 3The SCOOTER Store Marks Half-Millionth Life Changed 4Survival Rate Up to 100% for Late Stage Treatment of Anthrax Infections 2
(Date:5/24/2013)... -- Drugs commonly used to treat glaucoma may cause ... with vision, according to a new study. The ... to reduce eye pressure, have already been shown to ... the researchers said, suggesting that the new findings could ... should be conservative when prescribing these drugs, the researchers ...
(Date:5/24/2013)... Lake City, Utah (PRWEB) May 24, 2013 ... 2.0 , with exciting new enhancements for instructors and ... students stay more focused through personalize learning plan templates, ... new AnatomyOne release provides 500 new assessment questions, 5,000 ... and review notes. , AnatomyOne 2.0 is ...
(Date:5/24/2013)... BestSatelliteProviders.com the online satellite TV and ... compare the features and services offered by leading ... the rankings of the best rural Internet ... on their website. , BestSatelliteProviders.com – ... Matthews, the spokesperson for BestSatelliteProviders.com, “When consumers were ...
(Date:5/24/2013)... to the National Institutes of Health, Stevens Johnson Syndrome (SJS) ... the skin and mucous membranes. SJS occurs most commonly ... (i). In the early stages SJS presents flu-like symptoms, ... it affects the mucous membranes such as the eyes, mouth ... eye causes conjunctivitis (pink eye). Inflammation of the mouth ...
(Date:5/24/2013)... News) -- The number of U.S. patients admitted ... in an emergency room has increased by nearly ... study, conducted by researchers at the George Washington ... in Washington, D.C., found that patients wait five ... being admitted to the ICU. The researchers said ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... The Diversified Agency Services (DAS),unit of Omnicom ... position of,Executive Vice President and Director of ... will direct the client-centric and,brand-centric teams within ... resource of specialist agencies that support,the strategic ...
... is ,good news, for postmenopausal women taking anastrozole ... to previous study results, the cancer prevention drug ... cognitive performance, a new study found. , ... tamoxifen in preventing breast cancer recurrence in postmenopausal ...
... WINSTON-SALEM, N.C. Scientists at Wake Forest University School ... cancer gene called HNF1B have found a second independent ... increasing the number of genetic variants that may ... comparing the newly-discovered site with a previously discovered site ...
... , The guidelines are developed through a rigorous ... the field and a review committee of 21 international ... the first time both acute and chronic heart failure. ... patients with acute heart failure often develop chronic problems ...
... largest multi-institutional study to date examining the impact of ... individuals with suspected recurrent colorectal cancer, researchers found that ... patients, according to an article in the September issue ... The study was conducted at four sites throughout Australia ...
... Dr. Charmaine Yoest,President and CEO of Americans United ... that the daughter of McCain running mate,Sarah Palin is ... know this situation is not the ideal,Sarah Palin wished ... life,s,challenges is the true testament to our character. The ...
Cached Medicine News:Health News:Sharon Callahan Joins Diversified Agency Services Unit of Omnicom Group 2Health News:Breast Cancer Drug Not Tied to Cognitive Decline: Study 2Health News:Scientists find second site for prostate cancer gene 2Health News:PET scans lead to treatment changes in majority of colorectal cancer patients 2
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
This ENDOLOOP suture has a suture type - 0 Coated VICRYL and a 1.5 inch diameter....
... bring modern Data Management capabilities to the ... wide range of settings and definable options, ... the operator for identification, lot numbers, quality ... This data can then be transmitted to ...
Bartels Clostridium difficile Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficile Toxin A in human faecal specimens as an aid in the diagnosis of Clost...
Medicine Products: